Clinical trials
Therapy clinical trials
Below are recruiting therapy clinical trials, each written for real people, not researchers. We’re tracking 7,367 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07269782RecruitingPhase 2
Pre-surgery treatment for stage II-III lung cancer
This study tests two investigational drugs (HLX43 and serplulimab) given before surgery to people with stage II to III non-small cell lung cancer (NSCLC). The goal is to see if these drugs can shrink the tumor and make it easier to remove completely during surgery.
ShanghaiAges 18–75 - NCT07270718Recruiting
Beetroot powder for blood pressure in men with hypertension
This trial tests whether taking 20 grams of beetroot powder daily can help lower blood pressure and improve blood flow in men who already have high blood pressure under control with medication. Beetroot is rich in nitrates, which may relax blood vessels.
MoscowAges 18–60 - NCT07273201Recruiting
Comparing two arm exercises after stroke
This study tests two different types of arm exercises to see which one helps improve arm function better during early stroke recovery. It is for people who recently had a stroke on one side of their brain and are in the early stages of recovery.
CairoAges 50–60 - NCT07273357Recruiting
CDK4/6 inhibitors for older breast cancer patients
This study looks at how well older breast cancer patients (70 years and older) do when treated with a type of drug called a CDK4/6 inhibitor along with hormone therapy after surgery. The goal is to use simple health checks to help doctors decide if this treatment is right for you.
GävleAges 70 years+ - NCT07273903Recruiting
Tracking CIDP treatment with a smartwatch
This trial tests whether a smartwatch can help monitor how well subcutaneous immunoglobulin (fSCIG) works for people with CIDP who recently switched from IVIG or plan to switch. It aims to make treatment tracking easier and more convenient.
Düsseldorf, North Rhine-WestphaliaAges 18 years+ - NCT07275528Recruiting
Task training for movement and daily life in cerebral palsy
This trial tests if a specific type of physical therapy—task-oriented circuit training—helps children with hemiplegic cerebral palsy move better and take part in more activities. It may be a good fit for children with mild motor challenges who haven't had recent treatments or surgeries.
IslamabadAges 5–12 - NCT07276360RecruitingPhase 2
Short-course radiation for advanced cervical cancer in Uganda
This trial tests a shorter course of radiation therapy (fewer, higher-dose sessions) for women in Uganda with locally advanced cervical cancer. The goal is to see if this approach works as well as or better than standard radiation while reducing treatment time.
Kampala, KampalaAges 18 years+ - NCT07276490Recruiting
Pacemaker Study for Heart Block
This study tests how a pacemaker affects blood flow and heart health in people with heart block. It aims to see if special pacing settings can improve how the heart works.
Tallinn, HarjuAges 18–80 - NCT07278921Recruiting
Mosunetuzumab for relapsed follicular lymphoma
This trial tests a drug called Mosunetuzumab for people with follicular lymphoma that has come back or stopped responding after at least two previous treatments. It is available through a compassionate use program for those who have no other options.
MilanAges 18 years+ - NCT07281586RecruitingPhase 4
Switching from Prolia to a different osteoporosis drug
This trial tests if it's safe to switch from a long-term osteoporosis medication called Prolia to another treatment. It may help women and men who have been on Prolia for at least 3 years.
Douliu, TaiwanAges 50–85 - NCT07282275Recruiting
Does ongoing green light therapy improve health outcomes?
This trial looks at what happens when people continue using green light therapy over time. It aims to see if ongoing use leads to better health results.
New York, New YorkAges 18 years+ - NCT07282262RecruitingPhase 2
Ivosidenib for advanced bile duct cancer with IDH1 mutation
This trial tests the drug Ivosidenib for people with advanced bile duct cancer that has a specific genetic change called an IDH1 mutation. It may be an option if you haven't had chemotherapy yet or if your cancer returned more than 6 months after surgery.
BeijingAges 18–80 - NCT07282808Recruiting
Focal vs. full prostate treatment study
This trial tests whether targeting only the visible cancer spots on MRI (focal therapy) works as well as treating the whole prostate, for men with small, moderate-risk prostate cancer that hasn't spread.
SingaporeAges 21 years+ - NCT07282912RecruitingPhase 2
Extra treatment for certain digestive cancers with undetectable ctDNA
This trial tests if adding extra local treatments (like surgery or radiation) to usual care can improve outcomes for people with certain advanced digestive cancers that have spread to a limited number of sites. You may be eligible if your cancer has responded well to at least 4 months of therapy and your ctDNA (a sign of cancer in the blood) is undetectable.
New Haven, ConnecticutAges 18–80 - NCT07283757Recruiting
PTSD treatment for incarcerated men and women
This trial tests whether a group therapy for PTSD, called Cognitive Processing Therapy (CPT), helps people in prison. If you have PTSD and are on a waitlist for trauma treatment, this study may offer you a chance to get therapy sooner.
Madison, WisconsinAges 18 years+ - NCT07284433RecruitingPhase 1/Phase 2
Donor cell therapy for B-cell blood cancers
This trial tests a new treatment made from donor cells that target two proteins (CD19 and CD20) found on certain blood cancer cells. It may be an option for people whose B-cell lymphoma or chronic lymphocytic leukemia has come back or hasn't responded to at least two prior treatments.
Chicago, IllinoisAges 18 years+ - NCT07285694RecruitingPhase 1/Phase 2
Study of AB-3028 for advanced prostate cancer
This trial tests a new type of immune cell therapy (called AB-3028) designed to recognize and attack prostate cancer cells that have the PSMA protein on their surface. It's for people whose prostate cancer has spread and is no longer controlled by hormone therapy.
Duarte, CaliforniaAges 18 years+ - NCT07286500Recruiting
Sex, diabetes, and low blood sugar risk
This study looks at how sexual activity affects blood sugar levels and the risk of low blood sugar (hypoglycemia) in adults with diabetes who use insulin and a continuous glucose monitor. By participating, you'll help researchers understand the safety of sexual activity for people with diabetes.
WarsawAges 18 years+ - NCT07287059Recruiting
Wearable robot and virtual reality for hand recovery after stroke
This study tests if combining a wearable robotic glove with virtual reality exercises can help improve hand function in people who have had a stroke. It may be a good fit if you have some movement in your hand and arm but need more help.
Istanbul, BeykozAges 30–60 - NCT07287540Recruiting
Anti-inflammatory diet for gum disease treatment
This trial tests whether an anti-inflammatory diet can improve the results of standard gum disease treatment. It is for people diagnosed with periodontitis who are otherwise healthy and do not smoke.
RizeAges 20–65 - NCT07287995RecruitingPhase 1/Phase 2
Study of ASP2998 alone or with other therapies for solid tumors
This trial tests a new drug, ASP2998, given alone or with standard cancer treatments for people with advanced solid tumors, including certain types of lung, bladder, stomach, and breast cancers. The goal is to see if ASP2998 can help when other treatments have stopped working or are not an option.
Hackensack, New JerseyAges 18 years+ - NCT07288073RecruitingPhase 2
TIL Therapy for Advanced Skin Cancer Patients
This study tests a personalized cell therapy called TIL (tumor-infiltrating lymphocytes) for people with advanced skin cancers that have not responded to immunotherapy. Doctors take your tumor cells, grow immune cells from them, and then infuse them back to fight the cancer.
Boston, MassachusettsAges 18 years+ - NCT07288151RecruitingPhase 2
MDMA with Exposure Therapy for PTSD
This trial tests whether MDMA (the drug in ecstasy) combined with a type of talk therapy called massed exposure therapy can help treat PTSD. It may be an option if standard treatments haven't worked well enough.
Atlanta, GeorgiaAges 21–70 - NCT07288879RecruitingPhase 2
CAR T-cell therapy for relapsed or refractory DLBCL
This trial tests a new CAR T-cell therapy called MB-CART2019.1 for people with diffuse large B-cell lymphoma (DLBCL) that has come back or not responded after at least two prior treatments. The therapy uses your own immune cells to fight the cancer.
TokyoAges 18 years+
Hear when a new Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for therapy?
- Yes. Clin2 currently lists 7,367 recruiting therapy studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a therapy trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a therapy trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.